A Study of the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)

A phase 3 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 751 participants.

Also called NCT01682759

  • Study
  • In this atlas

Overview

Design
Interventional study; randomized; double masking; primary purpose treatment
Phase
Phase 3
Enrolled
  • 751 participants (enrolled count) (from the registry)
Sponsor
Registry
  • NCT NCT01682759
Other papers using this trial's data
  • A randomized, double-blind, non-inferiority trial evaluating the efficacy and safety of omarigliptin, a once-weekly DPP-4 inhibitor, or glimepiride in patients with type 2 diabetes inadequately controlled on metformin monotherapy Current medical research and opinion, 2017-10 DOI, PubMed 28548024

Courtesy of the U.S. National Library of Medicine.

Started
(actual) (from the registry)
Primary completion
(actual) (from the registry)
Completion
(actual) (from the registry)
Results first posted
(from the registry)
Countries
Not reported
Registry status
  • Completed (from the registry)

Technical summary

Registry record NCT01682759. Randomized; double masking; primary purpose treatment. Start 2012-09-10 (actual); primary completion 2015-01-26 (actual). Results posted on 2016-02-05.

The registry's words

Labels as the registry gives them, not rewritten.

Brief title
A Study of the Safety and Efficacy of Omarigliptin (MK-3102) Compared With Glimepiride in Participants With Type 2 Diabetes Mellitus With Inadequate Glycemic Control on Metformin (MK-3102-016)
Condition
Type 2 Diabetes Mellitus
Intervention (Drug)
Omarigliptin
Intervention (Drug)
Placebo to Omarigliptin
Intervention (Drug)
Glimepiride
Intervention (Drug)
Glimepiride Placebo
Intervention (Drug)
Metformin
Intervention (Drug)
Insulin Glargine
Lead sponsor
Merck Sharp & Dohme LLC (class: industry)

Record details

Record id
cardio:ct-nct01682759
Content hash
a1de1806e66b45beae91f69319da95dcb95220a2852b1eb28fb30076f228ba39